2018
DOI: 10.1002/stem.2781
|View full text |Cite
|
Sign up to set email alerts
|

Cornea-Derived Mesenchymal Stromal Cells Therapeutically Modulate Macrophage Immunophenotype and Angiogenic Function

Abstract: Macrophages are crucial drivers of inflammatory corneal neovascularization and thus are potential targets for immunomodulatory therapies. We hypothesized that therapeutic use of cornea-derived mesenchymal stromal cells (cMSCs) may alter the function of macrophages. We found that cMSCs can modulate the phenotype and angiogenic function of macrophages. In vitro, cMSCs induce apoptosis of macrophages while preferentially promoting a distinct CD14 CD16 CD163 CD206 immunophenotype that has significantly reduced ang… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
47
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 50 publications
(50 citation statements)
references
References 81 publications
(104 reference statements)
0
47
0
3
Order By: Relevance
“…To characterize the immune‐phenotype of EEMs compared with MQs, we examined the expression of CD206 and PD‐L1 of the two biologic CD14+ macrophage isolates used in this study. CD206, a mannose receptor, is a well‐known marker of M2 macrophages and our previously described MSC educated macrophages (MEMs); PD‐L1 an immune‐inhibitory checkpoint molecule . As shown in Figure B, C, CD206 and PD‐L1 were significantly higher in mean fluorescence intensity and percent cells from EEMs compared with the control MQs, indicating the MSC‐derived EVs were able to “educate” the macrophages to become more M2‐like.…”
Section: Resultsmentioning
confidence: 58%
See 1 more Smart Citation
“…To characterize the immune‐phenotype of EEMs compared with MQs, we examined the expression of CD206 and PD‐L1 of the two biologic CD14+ macrophage isolates used in this study. CD206, a mannose receptor, is a well‐known marker of M2 macrophages and our previously described MSC educated macrophages (MEMs); PD‐L1 an immune‐inhibitory checkpoint molecule . As shown in Figure B, C, CD206 and PD‐L1 were significantly higher in mean fluorescence intensity and percent cells from EEMs compared with the control MQs, indicating the MSC‐derived EVs were able to “educate” the macrophages to become more M2‐like.…”
Section: Resultsmentioning
confidence: 58%
“…Macrophage polarization, both in vitro and in vivo, can be induced by mesenchymal stromal/stem cell (MSC) paracrine activity . In mammalian models of ligament or tendon healing, MSC treatments increased the presence of endogenous M2 macrophages and associated anti‐inflammatory cytokines, which subsequently resulted in improved tendon and ligament healing .…”
Section: Introductionmentioning
confidence: 99%
“…Macrophages can produce diverse angiogenic factors, such as VEGF, PDGF, TGFb, FGF, [50][51][52] as well as antiangiogenic factors, including the potent PEDF and at times TSP-1. 17,18,53 PEDF directly targets PEDF-R-expressing endothelial cells to inhibit vasoproliferation and promote cell apoptosis. 23,37 In the eye, PEDF is located predominantly in RPE cells.…”
Section: Discussionmentioning
confidence: 99%
“…In this context, CNV as observed in various clinical conditions as well as in the laser-induced photocoagulation model, is associated with an inflammatory component. 14 Of relevance, mononuclear phagocytes (MPs) attracted to pathologic sites 15,16 are known to exert pro-and antiangiogenic effects, depending on their polarization resulting in the release of pro-and antiangiogenic factors inherently 17,18 or by stimulating the release of these factors from interacting cells, such as RPE. 14,19,20 However, whether modulation of relevant inflammation-associated CNV (including AMD, ocular histoplasmosis, Stargardt's disease, and degenerative myopia 21 ) by MPs depends in part upon their expression of b-adrenergic receptors, 22 has yet to be explored; moreover, the mechanism by which b-adrenoceptor inhibition in MPs could convey antiangiogenic properties to the choroid is also not known.…”
mentioning
confidence: 99%
“…A promising tool being investigated today is the use of mesenchymal stem cells (MSCs) or products derived from them to resolve existing fibrotic foci (Du et al, ; Liu et al, ; Coulson‐Thomas et al, ; Eslani et al, ). MSCs modulate the immune response when injected into injured tissues (Krampera et al, ; Bai et al, ; De Miguel et al, ).…”
Section: Lessons Learned From the Study Of The Corneamentioning
confidence: 99%